image description
Max Planck spin-off eversyn secures 1.6 million euros in seed capital

eversyn's technology could revolutionize the development of nutritional products and biopharmaceuticals

27-Mar-2025

eversyn, a spin-off of the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has successfully raised €1.6 million in seed capital to advance its innovative technology applications in the fields of nutrition and biopharmaceuticals. This investment follows a €1.1 million ...

more

image description
eversyn awarded with EXIST Research Transfer Grant for the Production of Glycans for Food and Pharma Industry

Spin-off Project of the Max Planck Institute Magdeburg

27-Oct-2022

eversyn is a start-up of the Department of Bioprocessing Engineering at the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg. The project has been awarded an EXIST Research Transfer grant of over € 900,000 to support its spin-off activities. eversyn will use its ...

more

image description
Innovative Research on Manufacturing of Viral Vaccines and Gene Therapies

"Innovation Prize 2021 of the German BioRegions" awarded to ContiVir

01-Dec-2021

ContiVir, a planned spin-off from the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has been awarded the 2021 "Innovation Prize of the German BioRegions" with regard to their research on and development of a purification tool to tackle vaccine bottlenecks. This ...

more

image description
Spin-off offers purification tool to tackle viral gene therapy manufacturing bottlenecks

Higher speed and increased yield thanks to membrane-based steric exclusion chromatography

22-Jun-2021

ContiVir, a spin-off project at the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has published results in the scientific journal Human Gene Therapy detailing the purification of Adeno-associated virus (AAV) using membrane-based steric exclusion chromatography (SXC), a ...

more

image description
Spin-off project successfully developed a COVID-19 vaccine candidate

Quick, efficient and scalable vaccine manufacturing: virus-like particle developed and produced

17-Sep-2020

With the current pandemic crisis, the lack of worldwide vaccine manufacturing capacity has become a serious concern. ContiVir, a spin-off project at the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has successfully produced a virus-like particle as a COVID-19 vaccine ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE